• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Emphysema Market Share

    ID: MRFR/Pharma/4354-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Emphysema Market Research Report By Type (Centrilobular, Panlobular), By Diagnosis (Imaging Test (X-Ray, Ct Scan), Lung Function Test), by Treatment (Medication (Antibiotics, Bronchodilators), Therapy, Surgery), by End-User-Global Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Emphysema Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Share

    Emphysema Market Share Analysis

    In the respiratory healthcare field, the Emphysema market is a vital sector that is currently going through intense rivalry forcing companies to use various strategies to secure their positions in the market. In this challenging environment, Emphysema business in the market depends on operating strategies for its continued success and viability. One of the major ways involves putting resources in research and development to bring about novel therapies and treatment methods. Companies want to distinguish themselves by proffering sophisticated respiratory solutions and technologies aimed at improving overall management of emphysema, a persistent lung disease. This strategy looks into addressing increasing demand for accurate and efficient solutions in respiratory care that meets inherent challenges posed by this progressive illness.

    The pricing models adopted play an instrumental role in determining companies’ share of the market within Emphysema market. Various pricing policies are often applied by most organizations such as premium prices for up-to-date treatments among other inhalation devices while others offer cheaper options so as to expand availability. The ability of these costs to be aligned with how much people feel they should pay enables companies to focus on various parts of the market which includes facilities seeking top-notch medical services as well as places with different economic backgrounds. For this reason, flexible pricing has enabled comprehensive coverage across these diverse markets characterized by patients who have different needs from those of providers.

    Strategic collaborations happen whenever there is a need for positioning oneself on the market with regard to its share within Emphysema industry. Organizations can establish partnerships with research institutions; pharmaceutical companies or even health care provision entities hence combining resources and expertise. These associations not only enhance knowledge transfer but also increase visibility of diagnostic and treatment options available. Partnering strengths make companies gain an edge when it comes to research capacities, knowing where consumer preferences lie as well as sales networks thus giving birth to a stronger marketplace.

    Market segmentation forms yet another important strategic tool that businesses use in order to reach different consumer groups within Emphysema market. Companies customize their treatment offerings and inhalation equipment to cater for the needs of different segments of customers such as pulmonologists, respiratory therapists and Emphysema patients. This enables organizations to fine-tune their marketing and product strategies that are designed specifically for each group thus strengthening their positions in the market.

    Comprehensive patient support programs, education initiatives and other consumer centric approaches greatly influence a company’s market share positioning. Some firms wanting satisfied health care providers as well as patients therefore go on to provide assistance services, sources of knowledge, accessible dialogue all which can be used by stakeholders in building trust with them. Satisfied clients according to research are likely to remain loyal which builds up on word-of-mouth communication that finally affects an organization’s share on the market.

    Market Summary

    The Global Emphysema Market is projected to grow from 13.5 USD Billion in 2024 to 22.7 USD Billion by 2035, indicating robust expansion.

    Key Market Trends & Highlights

    Global Emphysema Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate of 4.83 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 22.7 USD Billion, reflecting a substantial increase from 13.5 USD Billion in 2024.
    • The growth trajectory suggests a rising demand for innovative treatment options in the emphysema sector.
    • Growing adoption of advanced therapies due to increasing prevalence of respiratory diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 13.5 (USD Billion)
    2035 Market Size 22.7 (USD Billion)
    CAGR (2025-2035) 4.83%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Intrexon Corporation, Pulmonx Inc., Halozyme Therapeutics, Inc., Mariposa Health Limited, PneumRx, Uptake Medical Corporation, Icure Pharmaceuticals, Inc., Pfizer, Inc., BTG International, Olympus Corporation, Kamada Limited, Emphasys Medical, Inc.

    Market Trends

    The increasing prevalence of emphysema, driven by factors such as aging populations and environmental pollutants, underscores the urgent need for enhanced therapeutic strategies and public health initiatives.

    Centers for Disease Control and Prevention (CDC)

    Emphysema Market Market Drivers

    Growing Geriatric Population

    The aging population is a critical driver of the Global Global Emphysema Market Industry. As individuals age, the risk of developing respiratory diseases, including emphysema, increases significantly. The World Health Organization reports that the global population aged 60 years and older is expected to double by 2050, leading to a higher incidence of chronic respiratory conditions. This demographic shift necessitates enhanced healthcare services and treatment options tailored to older adults. Consequently, the Global Global Emphysema Market Industry is likely to see sustained growth, with a compound annual growth rate of 4.83% projected from 2025 to 2035, as the demand for effective management of emphysema rises.

    Advancements in Treatment Options

    Innovations in treatment methodologies are propelling the Global Global Emphysema Market Industry forward. New pharmacological therapies, including bronchodilators and corticosteroids, are being developed to enhance patient outcomes. Additionally, the emergence of biologics and targeted therapies offers promising avenues for managing emphysema. Clinical trials and research initiatives are ongoing, suggesting that these advancements could lead to improved efficacy and safety profiles for patients. As the industry evolves, the market is projected to grow, potentially reaching 22.7 USD Billion by 2035, reflecting the increasing investment in research and development within the Global Global Emphysema Market Industry.

    Increased Awareness and Education

    Rising awareness and education regarding respiratory health are influencing the Global Global Emphysema Market Industry positively. Public health campaigns and initiatives aimed at educating individuals about the risks associated with smoking and air pollution are gaining traction. These efforts are likely to lead to earlier diagnosis and treatment of emphysema, ultimately improving patient outcomes. Furthermore, healthcare providers are increasingly focusing on preventive measures, which may reduce the overall burden of the disease. As awareness continues to grow, the market is expected to expand, aligning with the projected increase in market value to 22.7 USD Billion by 2035.

    Market Trends and Growth Projections

    The Global Global Emphysema Market Industry is characterized by various trends that indicate its growth trajectory. The market is projected to expand significantly, with estimates suggesting a value of 22.7 USD Billion by 2035. This growth is underpinned by a compound annual growth rate of 4.83% from 2025 to 2035. Key trends include the increasing adoption of telemedicine for respiratory care, the integration of artificial intelligence in diagnostics, and the rise of personalized medicine approaches. These trends reflect the industry's adaptability and responsiveness to changing healthcare needs, positioning the Global Global Emphysema Market Industry for a robust future.

    Regulatory Support and Policy Initiatives

    Supportive regulatory frameworks and policy initiatives are fostering growth in the Global Global Emphysema Market Industry. Governments worldwide are implementing policies aimed at reducing tobacco use and improving air quality, which are crucial in combating respiratory diseases. Initiatives such as smoking cessation programs and stricter emissions regulations are likely to contribute to a decrease in new emphysema cases. This regulatory environment not only encourages innovation in treatment but also promotes public health. As a result, the Global Global Emphysema Market Industry is positioned for growth, with expectations of reaching 13.5 USD Billion in 2024.

    Rising Prevalence of Respiratory Diseases

    The Global Global Emphysema Market Industry is experiencing growth due to the increasing prevalence of respiratory diseases. Factors such as air pollution, smoking, and occupational hazards contribute significantly to the rise in emphysema cases. According to health statistics, millions of individuals are diagnosed with chronic obstructive pulmonary disease (COPD), which includes emphysema, highlighting the urgent need for effective treatment options. This growing patient population is expected to drive market demand, with projections indicating that the market could reach 13.5 USD Billion in 2024. As awareness of respiratory health continues to rise, the Global Global Emphysema Market Industry is likely to expand further.

    Market Segment Insights

    Emphysema Type Insights

    On the basis of type, the market is segmented into centrilobular and panlobular emphysema.

    Emphysema Diagnosis Insights

    On the basis of diagnosis, the market is segmented into imaging test, lung function test, and others. The imaging test is further segmented into chest X-ray and CT scan.

    Emphysema Treatment Insights

    On the basis of treatment, the market is segmented into medications, therapy, and surgery. Medications are further segmented into smoking cessation drugs, bronchodilators, inhaled steroids, antibiotics, and leukotriene modifiers. Therapy is further segmented into pulmonary rehabilitation, nutrition therapy, gene therapy, and supplemental oxygen. Surgery is further segmented into lung volume reduction surgery, lung transplant, and bullectomy.

    Emphysema End-User Insights

    On the basis of end-user, the market is segmented into hospitals and clinics, surgical centers, and others.

    Get more detailed insights about Emphysema Market Research Report - Forecast to 2032

    Regional Insights

    Key Companies in the Emphysema Market market include

    Industry Developments

    Future Outlook

    Emphysema Market Future Outlook

    The Global Emphysema Market is projected to grow at a 4.83% CAGR from 2024 to 2035, driven by advancements in treatment options, increasing prevalence, and heightened awareness.

    New opportunities lie in:

    • Develop innovative drug delivery systems to enhance treatment efficacy.
    • Expand telehealth services for remote patient monitoring and management.
    • Invest in personalized medicine approaches to tailor therapies for individual patients.

    By 2035, the Global Emphysema Market is expected to demonstrate robust growth, reflecting evolving treatment paradigms and increased patient engagement.

    Market Segmentation

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 12.23 (USD Billion)
    Market Size 2024 13.53 (USD Billion)
    Market Size 2032 19.83 (USD Billion)
    Compound Annual Growth Rate (CAGR) 4.64 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors Corporation, Pulmonx Inc., Halozyme Therapeutics, Inc., Mariposa Health Limited, PneumRx, Uptake Medical Corporation, Icure Pharmaceuticals, Inc., Pfizer, Inc., BTG International’s, Olympus Corporation, Kamada Limited, Emphasys Medical, Inc. and others.
      Key Market Opportunities Increasing population in urban areas across the globe and growing number of tobacco smokers.
      Key Market Drivers The growing prevalence of respiratory diseases is the major driver for the Emphysema Market.

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What is Emphysema?

    Emphysema is a lung disease characterized by shortness of breath, causing damage to the air sacs in the lungs.

    What is the CAGR of the Emphysema Market?

    Global Emphysema Market is expected to exhibit a strong 4.64% CAGR over the forecast period from 2024 to 2032.

    What is the major driver for the Emphysema Market?

    The growing prevalence of respiratory diseases is the major driver for the Emphysema Market.

    Which is the major regional Emphysema Market?

    The Americas dominate the Global Emphysema Market.

    What are the key players in the Emphysema Market?

    Leading players in the Emphysema Market include Pulmonx Inc., Intrexon Corporation, and Halozyme Therapeutics, among others.

    No Data Available

    Emphysema Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials